Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
Мақола

Advancing the Management of Anaplastic Thyroid Carcinoma: A Case Study of Multimodal Therapy and the Role of Emerging Nuclear Medicine Infrastructure in Bangladesh

Priyanka PodderSenior Medical Officer, Institute of Nuclear Medical Physics (INMP), AERE, SavarFatema Tuz ZohraSenior Medical Officer, Institute of Nuclear Medical Physics (INMP), AERE, SavarSamiul AlimExperimental Officer, Institute of Nuclear Medical Physics (INMP), AERE, SavarAbul HasnatSenior Scientific Officer, Institute of Nuclear Medical Physics (INMP), AERE, SavarRayhan AlamSenior Scientific Officer, Institute of Nuclear Medical Physics (INMP), AERE, SavarSanchoy Chandra BiswasarmaScientific Officer, National Institute of Nuclear Medicine and Allied Sciences (NINMAS), BSMMUMohammad Abdul MannanAssociate Professor, Labaid Cancer Hospital, DhakaMuhammad AhsanChief Scientific Officer, Atomic Energy Center (AEC), Dhaka
ABI

Аннотация

Anaplastic thyroid carcinoma (ATC) is an aggressive and rare form of thyroid cancer, representing 1-2% of thyroid malignancies but accounting for the majority of thyroid cancer-related deaths due to its rapid progression, invasiveness, and resistance to standard therapies. This report highlights the case of a 60-year-old male histopathologically diagnosed with ATC stage IV as there were lymph node metastases. The patient was managed with a multidisciplinary team approach and had total thyroidectomy followed by systemic chemotherapy and three-dimensional conformal radiotherapy. The reported case highlights the importance of aggressive, integrated therapeutic approaches in managing ATC, emphasizing personalized, multidisciplinary care, advanced radiotherapy techniques, and molecular-targeted therapies for improved outcomes. Bangladesh J. Nuclear Med. 28(1): 164-169, 2025

Ҳали таржима қилинмаган

Мавзулар

Идентификаторлар

Иқтибослар ва манбалар